TITLE

Accrued HIV evidence turns treatment dogma on its head

AUTHOR(S)
Check, Erika
PUB. DATE
August 2003
SOURCE
Nature;8/21/2003, Vol. 424 Issue 6951, p866
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Focuses on the possible health risk posed by HIV drugs in patients. Inefficacy of drugs in subduing virus in HIV positive patients; Comments of various researchers on HIV therapy; Thoughts over the distribution of drugs among various developing countries.
ACCESSION #
10613428

 

Related Articles

  • Structured Intermittent Therapy with Seven-Day Cycles of HAART for Chronic HIV Infection: A Pilot Study in São Paulo, Brazil. Casseb, Jorge; Da Silva Duarte, Alberto Jos // AIDS Patient Care & STDs;Jul2005, Vol. 19 Issue 7, p425 

    In the last 6 years, an impressive impact of the highly active antiretroviral therapy (HAART) on survival and morbidity in HIV-1–infected individuals has been attained. However, their prolonged use may induce metabolic adverse effects such as lipodistrophy, hypertension, diabetes...

  • POSITIVE THINKING with Noel Walsh. Walsh, Noel // Gay Community News;Oct2007, Issue 214, p34 

    The article reports that HIV-positive persons who take breaks in treatment are more than twice as likely to die or become ill than those who take continuous HIV treatment, according to a study conducted by the Strategies for the Management of Antiretroviral Therapy. The study also found that...

  • Global patient safety and antiretroviral drug–drug interactions in the resource-limited setting. Seden, Kay; Khoo, Saye H.; Back, David; Byakika-Kibwika, Pauline; Lamorde, Mohammed; Ryan, Mairin; Merry, Concepta // Journal of Antimicrobial Chemotherapy (JAC);Jan2013, Vol. 68 Issue 1, p1 

    Scale-up of HIV treatment services may have contributed to an increase in functional health facilities available in resource-limited settings and an increase in patient use of facilities and retention in care. As more patients are reached with medicines, monitoring patient safety is increasingly...

  • Reactivation of Hepatitis B Virus Replication Accompanied by Acute Hepatitis in Patients Receiving Highly Active Antiretroviral Therapy. Manegol, Christoph; Wywiol, Anett; Dietrich, Manfred; Chiwakata, Collins B.; Gunther, Stephan; Hannoun, Charles // Clinical Infectious Diseases;1/1/2001, Vol. 32 Issue 1, p144 

    Describes two case studies in which hepatitis B antibodies-positive patients experienced a sudden increase of hepatitis B virus replication during highly active antiretroviral therapy. Medical history of the patients; Clinical and virological course of patients; Treatment of hepatitis B...

  • Low Frequency of Renal Function Impairment During One-Year of Therapy with Tenofovir-Containing Regimens in the Real-World: A Case-Control Study. Padilla, Sergio; Gutiérrez, Félix; Masi, Mar; Cánovas, Víctor; Orozco, Carmen // AIDS Patient Care & STDs;Jul2005, Vol. 19 Issue 7, p421 

    Concern exists about the risk of nephrotoxicity using tenofovir (TDF) in HIV-infected patients. We performed a retrospective case-control study including 122 consecutive TDF-naive patients who started treatment with TDF-containing regimens and 194 patients receiving antiretroviral therapy with...

  • INTERVENCIÓN FARMACÉUTICA Y TIEMPO LIBRE DE HOSPITALIZACIÓN EN UNA COHORTE PACIENTES CON VIH/SIDA, MEDELLÍN-COLOMBIA. ESTRADA, Jorge; SÁNCHEZ, Jose; RESTREPO, Ana; ABAD, José; SERNA, Juan; SEGURA, Ángela // Vitae (01214004);2015 supemento 1, Vol. 22, pS89 

    The article discusses determination of the association between the pharmaceutical intervention and free time of hospitalization in a cohort of patients with HIV/AIDS, Medellin, Colombia. It mentions that the adherence is a key component of the antiretroviral therapy and the main cause to produce...

  • Preface [Hot topic: Treatment of Human Immunodeficiency Virus (HIV) Infection and Co-Pathologies (Guest Editor: Andreas Gruber)]. Gruber, Andreas // Current Medicinal Chemistry - Immunology, Endocrine & Metabolic ;Mar2004, Vol. 4 Issue 1, p1 

    In this issue experts in the field highlight recent advances in our understanding of HIV, the AIDS virus. The current issue will give an overview also of how the rapidly evolving knowledge about HIV may lead the way to new therapies not only for HIV but also for other diseases such as cancer,...

  • IS THE HUMAN LEUCOCYTE ANTIGEN B*5701 PREDICTED BY SEQUENCE VARIATIONS OF HIV-1 SUBTYPE F REVERSE TRANSCRIPTASE? Florea, D.; Oţelea, D.; Paraschiv, Simona; FrĐţilă, Mihaela; Streinu-Cercel, A. // Therapeutics, Pharmacology & Clinical Toxicology;2010, Vol. 14 Issue 3, p183 

    Objective: to evaluate the predictive value of mutations in position 245 of HIV reverse-transcriptase as a marker of the presence of HLA-B*5701 in HIV-1 subtype F1 infected patients. Methods: HIV drug resistance testing was performed by using the ViroSeq Genotyping System. Sequence-based HLA...

  • Treatment Options for HIV-Associated Tuberculosis. Onyebujoh, Philip Chukwuka; Ribeiro, Isabela; Whalen, Christopher Curtis // Journal of Infectious Diseases;8/15/2007 Supplement, Vol. 196, pS35 

    The vicious interaction between the human immunodeficiency virus (HIV) infection and tuberculosis (TB) pandemics poses special challenges to national control programs and individual physicians. Although recommendations for the treatment of TB in HIV-infected patients do not significantly differ...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics